APA (7th ed.) Citation

Abu-Humaidan, A. H. A., Ahmad, F. M., Awajan, D., Jarrar, R. F., & Alaridah, N. Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement. Wiley.

Chicago Style (17th ed.) Citation

Abu-Humaidan, Anas H. A., Fatima M. Ahmad, Dima Awajan, Raba’a F. Jarrar, and Nader Alaridah. Anti-SARS-Cov-2 S-RBD IgG Formed After BNT162b2 Vaccination Can Bind C1q and Activate Complement. Wiley.

MLA (9th ed.) Citation

Abu-Humaidan, Anas H. A., et al. Anti-SARS-Cov-2 S-RBD IgG Formed After BNT162b2 Vaccination Can Bind C1q and Activate Complement. Wiley.